Diabetes Clinical Trials in New York

Showing 1-20 of 325 trials

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

NCT06525259

The goal of the DISCOVERY study is to provide innovative critical information regarding the unique natural history of glycemic control, insulin sensitivity, and β-cell function, and their mechanistic determinates, in obese adolescents at risk for developing type 2 diabetes.

Diabetes Mellitus Type 2, Childhood-Onset

George Washington University3,600 participantsStarted Oct 2024

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +17 more locations

COMPLETEDNA< 1 mile

The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.

NCT06111508

The goal of this clinical trial is to compare the effect of a continuous glucose monitor (CGM) based titration algorithm to standard titration by self-monitoring blood glucose (SMBG) in participants with Type 2 Diabetes already using long acting insulin. The comparison aims to study the difference in glycemic control between the two therapies. Participants will be followed for 18 weeks and will be provided with Degludec insulin, insulin pen, and a CGM (Dexcom G6).

Type 2 Diabetes

University of Virginia30 participantsStarted Nov 2023

New York, New York, United States • Charlottesville, Virginia, United States

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.

Diabetes Trials in Other Cities

Texts for Diabetes Control Among Homeless Persons

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Cleaner Air for Lower Cardiometabolic Risk

A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes

Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight

A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting

Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

Closed Loop and Education for Hypoglycemia Awareness Restoration

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)

Other Conditions in New York